Top Industry Leaders in the Mouth Ulcer Treatment Market
Latest Mouth Ulcer Treatment Companies Update
August 2023: Otsuka Pharmaceutical Co., Ltd. announces positive Phase 3 trial results for their topical gel containing sucralfate (commonly used for treating stomach ulcers) for treating recurrent aphthous stomatitis (canker sores), a common type of mouth ulcer.May 2023: GlaxoSmithKline (GSK) acquires Innovate Biopharmaceuticals, gaining access to their investigational drug, IB204, a potential treatment for oral lichen planus, another type of mouth ulcer.April 2023: OraGen Pharmaceuticals expands its oral care product portfolio with the launch of OraSoothe™, a new topical oral pain reliever specifically formulated for mouth ulcers.February 2024: The American Academy of Oral and Maxillofacial Surgery (AAOMS) annual meeting will feature presentations on the latest advancements in oral healthcare, including management of mouth ulcers.July 2024: The International Association for Dental Research (IADR) General Session will showcase research on various oral health topics, potentially including mouth ulcer management.
List of Mouth Ulcer Treatment Key Companies in the Market
- Pfizer Inc.
- Church & Dwight Co.Inc.
- 3M
- Taro Pharmaceutical Industries Ltd.
- Bristol-Myers Squibb Company
- BLISTEX INC.
- GlaxoSmithKline plc.
- ECR Pharmaceuticals
- Sannova
- Reckitt Benckiser
- Sunstar
- Blairex Laboratories
- Sanjin Pharmaceutical
- Joincare Pharmaceutical
- Sinclair Pharma
- Colgate-Palmolive Company